COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH: Menu

A Phase III, Randomized, Double-Blind, Placebo Controlled Trial to Evaluate the Efficacy and Safety of Nitazoxanide in the Treatment of Uncomplicated Influenza

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT03336619
Recruitment Status : Completed
First Posted : November 8, 2017
Last Update Posted : May 18, 2020
Information provided by (Responsible Party):
Romark Laboratories L.C.

No Study Results Posted on for this Study
Recruitment Status : Completed
Actual Primary Completion Date : April 17, 2019
Actual Study Completion Date : April 17, 2019
Certification/Extension First Submitted : April 14, 2020